伊利诺伊州和威斯康星州电子烟相关肺损伤最终报告
2019年7月威斯康星州卫生服务部和伊利诺伊州公共卫生部接到电子烟相关肺损伤报告并启动联合公共卫生调查。病例定义为症状出现前90天内使用电子烟装置及相关产品、影像学有肺部浸润且排除其他原因者。共98例病例,79%为男性,中位年龄21岁;97%有呼吸道症状,77%有胃肠道症状,100%有全身症状,全部有双肺浸润。95%住院,26%接受气管插管和机械通气,报告2例死亡;89%报告在电子烟装置中使用四氢大麻酚产品。伊利诺伊州症候群监测显示2019年6月至8月严重呼吸系统疾病相关就诊的月均率是2018年同期的两倍。
要点
- 98例电子烟相关肺损伤病例中,95%住院,26%接受气管插管和机械通气,报告2例死亡。
- 全部病例均有双肺浸润,97%有呼吸道症状,77%有胃肠道症状,100%有全身症状。
- 89%的病例报告在电子烟装置中使用四氢大麻酚产品,涉及多种产品和装置。
- 病例定义为症状出现前90天内使用电子烟装置及相关产品、影像学有肺部浸润且疾病不能归因于其他原因。
- 伊利诺伊州2019年6月至8月严重呼吸系统疾病相关就诊月均率是2018年同期的两倍。
适用人群与场景
- 报告在症状出现前90天内使用电子烟装置及相关产品者。
- 影像学有肺部浸润且疾病不能归因于其他原因者。
诊断标准与关键阈值
- 病例定义:症状出现前90天内报告使用电子烟装置及相关产品,影像学有肺部浸润,且疾病不能归因于其他原因。
研究设计与关键结果
- 共98例病例,79%为男性,中位年龄21岁。
- 97%有呼吸道症状,77%有胃肠道症状,100%有全身症状。
- 全部病例胸部影像学均有双肺浸润。
- 95%住院,26%接受气管插管和机械通气,报告2例死亡。
- 89%报告在电子烟装置中使用四氢大麻酚产品,涉及多种产品和装置。
- 伊利诺伊州症候群监测显示2019年6月至8月严重呼吸系统疾病相关就诊月均率是2018年同期的两倍。
证据类型、等级与局限
- 证据类型:公共卫生调查。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,尽管导致损伤的确切物质尚未确定,这一初始疾病聚集代表一种或多种新兴临床综合征。
- 作者认为,需要额外工作来刻画病理生理学并确定确切病因。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: E-cigarettes are battery-operated devices that heat a liquid and deliver an aerosolized product to the user. Pulmonary illnesses related to e-cigarette use have been reported, but no large series has been described. In July 2019, the Wisconsin Department of Health Services and the Illinois Department of Public Health received reports of lung injury associated with the use of e-cigarettes (also called vaping) and launched a coordinated public health investigation.
METHODS: We defined case patients as persons who reported use of e-cigarette devices and related products in the 90 days before symptom onset and had pulmonary infiltrates on imaging and whose illnesses were not attributed to other causes. Medical record abstraction and case patient interviews were conducted with the use of standardized tools.
RESULTS: There were 98 case patients, 79% of whom were male; the median age of the patients was 21 years. The majority of patients presented with respiratory symptoms (97%), gastrointestinal symptoms (77%), and constitutional symptoms (100%). All case patients had bilateral infiltrates on chest imaging. A total of 95% of the patients were hospitalized, 26% underwent intubation and mechanical ventilation, and two deaths were reported. A total of 89% of the patients reported having used tetrahydrocannabinol products in e-cigarette devices, although a wide variety of products and devices was reported. Syndromic surveillance data from Illinois showed that the mean monthly rate of visits related to severe respiratory illness in June through August of 2019 was twice the rate that was observed in the same months in 2018.
CONCLUSIONS: Case patients presented with similar clinical characteristics. Although the definitive substance or substances contributing to injury have not been determined, this initial cluster of illnesses represents an emerging clinical syndrome or syndromes. Additional work is needed to characterize the pathophysiology and to identify the definitive causes.
参考来源
- Layden JE, Ghinai I, Pray I, et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report. N Engl J Med. 2019. PMID: 31491072. doi:10.1056/NEJMoa1911614
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。